1.Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Jung Min HA ; Won SOHN ; Ju Yeon CHO ; Jeung Hui PYO ; Kyu CHOI ; Dong Hyun SINN ; Geum Youn GWAK ; Moon Seok CHOI ; Joon Hyeok LEE ; Kwang Chul KOH ; Seung Woon PAIK ; Byung Chul YOO ; Yong Han PAIK
Clinical and Molecular Hepatology 2015;21(3):232-241
BACKGROUND/AIMS: Hepatitis-B-related acute-on-chronic liver failure has a poor prognosis. However, the advent of potent oral antiviral agents means that some patients can now recover with medical treatment. We aimed to identify the prognostic factors for hepatitis-B-related acute-on-chronic liver failure including the initial as well as the dynamically changing clinical parameters during admission. METHODS: Sixty-seven patients were retrospectively enrolled from 2003 to 2012 at Samsung Medical Center. The patients were classified into three categories: Recovery group (n=23), Liver transplantation group (n=28), and Death group (n=16). The Liver transplantation and Death groups were combined into an Unfavorable prognosis group. We analyzed the prognostic factors including the Model for End-Stage Liver Disease (MELD) scores determined at 3-day intervals. RESULTS: A multivariable analysis showed that the unfavorable prognostic factors were a high initial MELD score (> or =28) (odds ratio [OR] =6.64, p=0.015), moderate-to-severe ascites at admission (OR=6.71, P=0.012), and the aggravation of hepatic encephalopathy during hospitalization (> or =grade III) (OR=15.41, P=0.013). Compared with the baseline level, significant reductions in the MELD scores were observed on the 7th day after admission in the Recovery group (P=0.016). CONCLUSIONS: Dynamic changes in clinical parameters during admission are useful prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Acute-On-Chronic Liver Failure/*diagnosis/drug therapy/etiology
;
Adult
;
Aged
;
Antibodies, Monoclonal, Murine-Derived/therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Antiviral Agents/therapeutic use
;
Cyclophosphamide/therapeutic use
;
DNA, Viral/analysis
;
Doxorubicin/therapeutic use
;
Female
;
Hepatitis B virus/genetics
;
Hepatitis B, Chronic/complications/*diagnosis/drug therapy
;
Hospitalization
;
Humans
;
Liver Transplantation
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Prednisone/therapeutic use
;
Prognosis
;
Retrospective Studies
;
Severity of Illness Index
;
Vincristine/therapeutic use
;
Young Adult